To the Editor: Eosinophilic esophagitis (EoE) is a chronic, immune-mediated esophageal disease characterized by symptoms of esophageal dysfunction in combination with evidence of eosinophilpredominant esophageal inflammation. 1 EoE has been closely linked with a personal and family history of atopic disorders, including asthma, eczema, rhinitis, and food allergies. However, the prevalence of atopic disease in patients with EoE varies widely between studies, as estimates have mostly been based on small cohorts. 2 Two large database searches estimated prevalence based on diagnostic codes rather than systematic chart review of clinical and pathologic features of individual patients. 3, 4 The goal of this institutional review boarde approved study was to provide an estimate of prevalence of these atopic diseases in a large singlecenter EoE population. We identified 449 patients who presented with clinical and pathological features of EoE and received an esophageal biopsy between January 1, 2005, and June 30, 2015, at the Cleveland Clinic; we examined their electronic medical records for diagnoses or medical history of asthma, atopic dermatitis, and allergic rhinitis. Demographic information, esophageal disease characteristics, family history of atopy, peripheral eosinophil counts, and serum IgE levels were also extracted from medical records. Categorical factors were evaluated using Pearson 2 tests. Normally distributed continuous measures were compared using 2-sample t tests. Other variables were compared using Wilcoxon rank sum tests. Variables with missing responses were excluded from the analysis.
Of the 449 patients with EoE, 348 (77.5%) had at least 1 atopic disease, 215 (47.9%) had more than 1 atopic disease, and 97 (21.6%) had all 3 atopic diatheses (Table I) . Patients with atopic diseases tended to be younger, more likely to have a family history of atopy, and have significantly higher peripheral eosinophils and serum IgE levels (Table II) .
The prevalence of asthma, allergic rhinitis, and atopic dermatitis in the United States is estimated to be 22.3%, 19.1%, and 8.3%, respectively. 5 In contrast, the estimated prevalence of asthma, allergic rhinitis, and atopic dermatitis in our EoE population was 39.0%, 61.9%, and 46.1%, respectively, suggesting a strong association between atopic diseases and EoE. Furthermore, patients with co-existing EoE and any of the 3 atopic diseases had significantly higher peripheral eosinophil counts and higher IgE levels, suggesting that a systemic process may be occurring in this subset of patients.
Limitations of this study included its retrospective design and our reliance on chart review and self-reported data. Patient data were limited by what individual providers included in their clinical visit notes or workup results. For example, peripheral eosinophil counts and serum IgE levels were available for 348 (77.5%) and 113 (25.1%) patients with EoE, respectively. Medical history and new clinical diagnoses of atopic diseases were included in this study, although medical history or family history of atopic diseases may be overreported or incompletely elicited in some individuals. Notably, temporal relationship between atopic disease onset and EoE onset was not examined in this study.
Given these results, we stress that physicians need to be vigilant of this association when screening patients with atopic diseases or esophageal dysfunction. 
